Device Trial Radar · NCT00180570
SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes
Last checked: Nov 20, 2026Latest source record: Mar 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
385
Actual
Start
Jan 1997
Primary completion
Not stated
Study completion Jan 2006
Sponsor
- Lead sponsor
- Guidant CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 16, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomised Comparison with regards to complication rate and electrical measurements of atrial leads with different fixation mechnism
Conditions
- Bradycardia
Interventions
FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary objective of this study is to compare repositioning rate due to threshold > 3.0 V @ 0.5 ms or P-wave < 0.8 mV between FineLine II Sterox 4480 and 4470, and between 4456 and 4470.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sahlgrenska Sjukhuset i Göteborg Sweden,
Gothenburg, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.